Conference
Co-Host

Local Host

Helix
Sponsors

Conference Sponsors

Industry Sponsors

Investor Registration Form

Fields marked with * are required. Please carefully read all the instructions.
For more information, please contact BIO NVC customer service:
Email: bionvc@bio.org
Phone: 866.356.5155, +1.202.962.6666 .

  Prefix First Name MI Last Name Suffix
Name *
Title *
Company *
Address *
Address
City *  State     ZIP *  
Country *
  Country Code   Area Code   Number
Direct Phone *      
Direct Fax      
E-mail *
(Required for registration to be processed)
Investor Type *
If 'other' please describe
One-on-Ones *

BIO will arrange one-on-ones between investors & company executives.

 No Answer
 Yes, I will participate in one-on-ones
 No, I will not participate in one-on-ones
Funds Currently Available to Invest
(check all that apply)		  Angel and seed level
 0-$10M
 $10-50M
 $50-100M
 $100-500M
 Greater than $500M
Typical Investment Size
(check all that apply)		  Angel and seed level
 0-$10M
 $10-50M
 $50-100M
 $100-500M
Typical Overall Round Size
(check all that apply)		  Angel and seed level
 0-$10M
 $10-50M
 $50-100M
 $100-500M
Valutation Sensitivity
(check all that apply)		  Up to angel and seed level
 Up to $10M
 Up to $25M
 Up to $50M
 Up to $100M
 Greater than $100M
Preferred Round for Initial Participation
(check all that apply)		  Angel or seed level
 Series A round
 Series B round
 Series C round or greater
 Mezzanine or crossover round
Investment Criteria
(check all that apply)		  Platform-based
 Preclinical stage
 POC stage
 Phase 1 clinical stage
 Board participation
 Lead investor
 Regional Focus
 Virtual company strategy
 Integrated company strategy
Investment Focus
(check all that apply)		  Platform companies
 Therapeutic lead or pipeline
 Personalized medicine
Therapeutic categories
(check all that apply)
 ADMET
 Agbio / Veterinary / Environmental
 Antibodies
 Autoimmune / Inflammation
 Bioinformatics
 Biomanufacturing
 Biomaterial / Skin / Wound
 Biopharmaceuticals
 Blood products / substitutes
 Cancer
 Cardiovascular
 Chemistry
 CNS / Neurology
 Computational Chemistry / Biology
 CRO
 Dental
 Dermatology
 Diagnostics / Imaging
 Drug Delivery
 Drug Development
 Drug Discovery
 Enabling Technology
 Environmental
 Enzymes
 Functional Genetics
  Gene / Cell Therapy
 Genomics
 Hematology
 High Throughput Screening
 in vitro Diagnostics
 Infectious Diseases
 Metabolic
 Microarrays
 Microfluidics
 Musculoskeletal
 Nutraceuticals
 Ophthalmic
 Other
 Pharmaceutical
 Pharmacogenetics
 Proteomics
 Pulmonary
 Renal
 Reproductive
 Service
 Supply
 Transplant
 Urological
 Vaccines
 Veterinary
Company Board and Management Criteria
(check all that apply)		  Independent board members
 Core senior management
 Scientific advisory or advisory board
Location of Investments (check all that apply)
 USA
Northern California
Southern California
Massachusetts
Connecticut, New Jersey, New York, Pennsylvania
Delaware, Maryland, Virginia, D.C.
Illinois, Indiana, Iowa, Michigan, Minnesota, Missouri, Nebraska, Ohio, Wisconsin
North Carolina
Idaho, Montana, Oregon, Washington
Other
 Canada
Alberta British Columbia Manitoba Saskatchewan
New Brunswick, Newfoundland, Labrador, Nova Scotia, Ontario, Prince Edward Island, Quebec
Other
 Europe
 Asia
 Pacifica
 Worldwide
Confirmation of registration will be issued by e-mail with in two business days upon receipt of registration request. All registration requests are subject to review and approval by BIO.